Growth Opportunities in Probiotics Demand Responsible Marketing and Positioning

  • On Demand


Digital summits are a new experience in online education, optimized for professionals who need deeper-dive information to help them make key business decisions. These immersive education programs are presented by thought leaders in the probiotics industry, addressing the industry's top challenges.

As a registered user, you can attend the live event on January 15th to view video content in real time with live Q and A interaction with the presenters, or you can watch the content on-demand after the live event.

Inside the Digital Summit platform, users have access to a resource library featuring premium content from INSIDER, along with whitepapers, briefs, and webinar content from the event underwriters. You'll have the ability to create your own profile, pose questions, start a dialogue, download resource material, and much more.


  • On Demand

    Global Market Opportunities Ewa Hudson Probiotics received an extremely strong market response in Asia, but their scope in terms of the types of ingredients and finished products available has grown tremendously throughout the globe. Get a global view on the major trends affecting the market, some of the new product launches that illustrate the trends, and how companies can position their own products or develop new products that will capture part of this growing market.
    • Ewa Hudson Research Program Manager Euromonitor International
  • On Demand

    Probiotics and the GRAS vs. NDIN Question Claire Kruger, Ph.D., DABT and Dietrich Conze, Ph.D. Introduction of a probiotic into the United States requires an understanding of the regulatory pathway as well as the underlying science. Will a self-determination or FDA notification of GRAS (generally recognized as safe) affirmation fulfill the need or will filing of a new dietary ingredient notification (NDIN) be necessary? Stakeholders are increasing pressure to improve the current regulatory paradigm of probiotics, and the industry must deal with the confusion and controversy. The nature and quality of scientific evidence used to document safety of probiotics will be explored as well as the manner in which it is organized and presented for each regulatory path.
  • On Demand

    Persistence of Probiotics in the Gastrointestinal Tract and the Role of Synbiotics Robert Hutkins, Ph.D. Dietary strategies for improving gut health have focused primarily on probiotics, prebiotics and, more recently, synbiotics (a combination of pre- and probiotics). Although many commercially available probiotic strains are capable of surviving gastrointestinal (GI) digestion, they are still rapidly eliminated after consumption has ended. The inability of probiotic bacteria to persist in the human intestinal tract has been attributed to colonization resistance, whereby the resident gut microbiota restricts access of exogenous organisms. Synbiotics may, however, provide a means for enhancing persistence of targeted probiotic strains. One important criterion for formulating synbiotic preparation is the probiotic strain should have the ability to utilize the prebiotic in the intestinal environment. Research shows different strains from the same species do not always have the same metabolic capacity to use a specific prebiotic. Rational selection of synbiotic combinations would also account for ecological considerations. That is, does the prebiotic provide a competitive advantage in the GI tract? This lecture will address these issues and provide suggestions for rational formulation of synbiotics.


  • Dietrich Conze, Ph.D. Senior Science Director, Spherix Consulting

    Dietrich Conze, Ph.D., is a senior science director at Spherix. He is a cell and molecular biologist specializing in the signal transduction pathways that regulate innate and adaptive immunity, inflammation and tumorigenesis. As part of Spherix’s Health Sciences Division, Conze is responsible for supporting the regulatory and scientific needs of his clients. Conze received his doctorate from the cell and molecular biology program at the University of Vermont and continued his scientific pursuits as a postdoctoral fellow in the laboratory of immune cell biology at the National Cancer Institute (NCI). He has more than 15 years of experience conducting scientific research, and has authored and contributed to a wide variety of peer-reviewed publications.

  • Ewa Hudson Research Program Manager, Euromonitor International

    Ewa Hudson manages the research program for the global health and wellness industry at Euromonitor International, which she joined in March 2003. In her current post, Hudson has direct responsibility over the content and quality of Euromonitor's Health and Wellness Food and Beverages research. She is also responsible for working with the international client base of Euromonitor's online Health and Wellness Foods and Beverages Passport. Before joining Euromonitor, Hudson worked as a senior analyst for Snapshots International, overseeing consumer market research for Eastern Europe, the U.K. and the United States. She has a master's degree in economics from the University of Poznan, Poland, and has also studied postgraduate marketing at the University of Westminster in London.

  • Robert Hutkins, Ph.D. Senior Science Director, University of Nebraska

    Robert Hutkins, Ph.D., is the Khem Shahani professor of food microbiology at the University of Nebraska. The Hutkins Lab studies bacteria important in human health and fermented foods. The lab is particularly interested in understanding factors that affect persistence of probiotic lactic acid bacteria and Bifidobacteria in the gastrointestinal (GI) tract, specifically, how these probiotics shift the intestinal microbiota in humans and animals. He also studies how some prebiotics inhibit pathogen attachment in the intestinal tract. Hutkins has published widely on prebiotics and probiotics. He is also the author of the textbook, "Microbiology and Technology of Fermented Foods."

  • Claire Kruger, Ph.D., DABT President, Spherix Consulting

    Claire Kruger, Ph.D., is president of Spherix Consulting, a wholly-owned subsidiary of ChromaDex Inc. With more than 25 years of consulting experience, her primary area of expertise is in foods, consumer products and pharmaceuticals, where she provides scientific, regulatory and strategic support to clients in both the United States and international regulatory arenas. She has been involved in the safety evaluation of a variety of consumer products and the safety of foods, novel foods, food additives, GRAS (generally recognized as safe) substances, dietary supplements, food contact substances and food contaminants. She has developed novel approaches for evaluating the safety of bioactive components and complex botanical extracts, and has employed these approaches in completing GRAS determinations for several novel bioactive functional ingredients, including probiotics and prebiotics.